These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 2878995

  • 1. Analgesic and anti-inflammatory activities in rats of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), and its intestinal damage.
    Hidaka T, Hosoe K, Yamashita T, Watanabe K, Hiramatsu Y, Fujimura H.
    J Pharm Pharmacol; 1986 Oct; 38(10):748-53. PubMed ID: 2878995
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
    Hidaka T, Hosoe K, Ariki Y, Takeo K, Yamashita T, Katsumi I, Kondo H, Yamashita K, Watanabe K.
    Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
    [Abstract] [Full Text] [Related]

  • 3. Effect of alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), a new anti-inflammatory drug, on the established adjuvant arthritis in rats.
    Hidaka T, Hosoe K, Yamashita T, Watanabe K.
    Jpn J Pharmacol; 1986 Oct; 42(2):181-7. PubMed ID: 3795622
    [Abstract] [Full Text] [Related]

  • 4. The effect of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), a new anti-inflammatory drug, on leucocyte migration in rat carrageenan pleurisy.
    Hidaka T, Hosoe K, Katsumi I, Yamashita T, Watanabe K.
    J Pharm Pharmacol; 1986 Mar; 38(3):244-7. PubMed ID: 2871169
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
    Hidaka T, Takeo K, Hosoe K, Katsumi I, Yamashita T, Watanabe K.
    Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H, Yokoyama Y, Motoyoshi S, Ishii K, Imazu C, Seto Y, Kadokawa T, Shimizu M.
    Arzneimittelforschung; 1983 Jul; 33(11):1555-69. PubMed ID: 6607053
    [Abstract] [Full Text] [Related]

  • 8. [Anti-inflammatory, analgesic and anti-pyretic activities of a new anti-inflammatory compound, 2-[4-(3-methyl-2-butenyl)phenyl] propionic acid (TA), in experimental animals].
    Higuchi S, Amanuma F, Okuyama S, Shioiri Y, Tanaka N, Arai I, Isobe Y, Otomo S, Aihara H.
    Nihon Yakurigaku Zasshi; 1987 May; 89(5):269-77. PubMed ID: 3497851
    [Abstract] [Full Text] [Related]

  • 9. [Anti-inflammatory, analgesic and antipyretic activities of alpha-(p-thenoylphenyl)-propionic acid (TN-762) (author's transl)].
    Fujimura H, Tsurumi K, Hasegawa J, Yanagihara M, Hiramatsu Y, Maekawa K.
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):123-36. PubMed ID: 6979498
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacological study of kako-bushi-matsu: analgesic action and acute toxicity].
    Murayama M, Namiki Y.
    Nihon Yakurigaku Zasshi; 1989 Nov; 94(5):309-17. PubMed ID: 2613110
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
    Grau M, Guasch J, Montero JL, Felipe A, Carrasco E, Juliá S.
    Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
    [Abstract] [Full Text] [Related]

  • 12. [The analgesic and antipyretic effects of a non-steroidal antiinflammatory agent, EB-382, in experimental animals].
    Fujiyoshi T, Iida H, Saito M, Ikeda K, Yamaura T, Uematsu T.
    Nihon Yakurigaku Zasshi; 1986 May; 87(5):527-36. PubMed ID: 3488251
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.
    Tanaka K, Shimotori T, Makino S, Aikawa Y, Inaba T, Yoshida C, Takano S.
    Arzneimittelforschung; 1992 Jul; 42(7):935-44. PubMed ID: 1418059
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the antiexudative and antiproliferative activities of non-steroidal anti-inflammatory drugs in inflammatory models developed in rats by subcutaneous implantation of bacterial cell walls from the dental plaque.
    Guimarães SA, Akatsu T, Tago EM, Consolaro A.
    Inflammation; 1996 Dec; 20(6):623-36. PubMed ID: 8979151
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological properties of the novel non-steroidal antiinflammatory agent N-methoxy-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)pyrrolidin-2 -one.
    Shirota H, Chiba K, Ono H, Yamamoto H, Kobayashi S, Terato K, Ikuta H, Yamatsu I, Katayama K.
    Arzneimittelforschung; 1987 Aug; 37(8):930-6. PubMed ID: 3499909
    [Abstract] [Full Text] [Related]

  • 16. [Inhibitory effect of AD-1590, a non-steroidal anti-inflammatory drug, on allergic inflammation in mice and rats].
    Nakamura H, Motoyoshi S, Ishii K, Kadokawa T.
    Nihon Yakurigaku Zasshi; 1988 Jul; 92(1):29-38. PubMed ID: 3265405
    [Abstract] [Full Text] [Related]

  • 17. [Anti-inflammatory, analgesic and anti-pyretic activities of a non-steroidal anti-inflammatory drug, etofenamate, in experimental animals].
    Nakamura H, Motoyoshi S, Imazu C, Ishii K, Yokoyama Y, Seto Y, Kadokawa T, Shimizu M.
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):125-35. PubMed ID: 6983482
    [Abstract] [Full Text] [Related]

  • 18. Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liability.
    Wong S, Lee SJ, Frierson MR, Proch J, Miskowski TA, Rigby BS, Schmolka SJ, Naismith RW, Kreutzer DC, Lindquist R.
    Agents Actions; 1992 Sep; 37(1-2):90-8. PubMed ID: 1456184
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats.
    Jarosz M, Szkaradek N, Marona H, Nowak G, Młyniec K, Librowski T.
    Inflammopharmacology; 2017 Dec; 25(6):653-663. PubMed ID: 28536986
    [Abstract] [Full Text] [Related]

  • 20. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs.
    Okuyama S, Aihara H.
    Jpn J Pharmacol; 1984 Jun; 35(2):95-103. PubMed ID: 6146738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.